Completed
Association of CPM with Reduction in Mortality Selection Bias Stage
Class Central Classrooms beta
YouTube videos curated by Class Central.
Classroom Contents
Clinical and Genetic Determinants of Contralateral Breast Cancer - Webinar - Ambry Genetics
Automatically move to the next video in the Classroom when playback concludes
- 1 Intro
- 2 Disclosures
- 3 OBJECTIVES
- 4 Why is it Important to Know About CBC?
- 5 Treatment Preference
- 6 Increase in Bilateral Mastectomy Rates
- 7 Bilateral Mastectomy Rates are Age Dependent
- 8 Overall Surgery Trends for Stage 1-1 Breast Cancer Patients
- 9 Risk Factors for CBC
- 10 CBC Risk-Clinical Trials
- 11 Decreasing CBC with Anti-Estrogen Treatment (ER+ Tumors)
- 12 RISK OF CBC and RADIATION THERAPY FOR BREAST CANCER
- 13 CBC Risk and Family History Ten Year Cumulative Risks
- 14 CBC RISK in BRCA MUTATION CARRIERS-META-ANALYSIS of 20 STUDIES
- 15 CBC risk for Non-BRCA Genes
- 16 Prevalence of Genetic Mutations 2012-2015
- 17 Prevalence of Genetic Mutations by Race/Ethnicity
- 18 Conclusions
- 19 Manchester Guidelines
- 20 CBC Prediction Models
- 21 Clinical Application-CBC Prediction
- 22 CBC and Survival
- 23 Association of CPM with Reduction in Mortality Selection Bias Stage
- 24 BRCA carriers and Survival with Bilateral Mastectomy
- 25 Why Patients Choose CPM
- 26 THANK YOU
